Antibodies to ds-DNA and antinuclear antibody (ANA) were the most prevalent autoantibodies observed in these SLE cohorts as determined by ELISA, which were detected in 100% (134/134) and 97.02% (130/134) of SLE patients, respectively (Table 1). This evidence concerns the gene BTG3 and systemic lupus erythematosus.